336 related articles for article (PubMed ID: 36296329)
21. Additive effect of indomethacin and methotrexate on suppression of growth in rats.
Iqbal MP; Saeed SA; Pertani S; Mehboobali N
Biopharm Drug Dispos; 1999 Nov; 20(8):389-95. PubMed ID: 10870096
[TBL] [Abstract][Full Text] [Related]
22. Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implications.
Katturajan R; S V; Rasool M; Evan Prince S
Toxicology; 2021 Sep; 461():152909. PubMed ID: 34453959
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice.
Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
Mutat Res; 2008; 655(1-2):59-67. PubMed ID: 18678279
[TBL] [Abstract][Full Text] [Related]
24. Complete clinical and functional recovery following low-dose methotrexate related paraparesis in a patient with compound c.1298A>C AND c.677C>T MTHFR polymorphism: A case report.
Saviola G; Abdi-Ali L; Sacco S; Comini L; Plewnia K; Rossi M; Orrico A
Medicine (Baltimore); 2018 Dec; 97(49):e13350. PubMed ID: 30544400
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate: Implications of pharmacogenetics in the treatment of patients with Rheumatoid Arthritis.
Torres RP; Santos FP; Branco JC
ARP Rheumatol; 2022 Oct; 1(3):225-229. PubMed ID: 35724450
[TBL] [Abstract][Full Text] [Related]
26. Effects of methotrexate on RNA and purine synthesis of astrocytes in primary culture.
Bruce-Gregorios JH; Agarwal RP; Oracion A; Ramirez A; Lin L
J Neuropathol Exp Neurol; 1991 Nov; 50(6):770-8. PubMed ID: 1721086
[TBL] [Abstract][Full Text] [Related]
27. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
Goldman ID; Matherly LH
NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
[TBL] [Abstract][Full Text] [Related]
28. Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia/lymphoma: a retrospective study.
Mandal P; Samaddar S; Chandra J; Parakh N; Goel M
Indian J Hematol Blood Transfus; 2020 Jul; 36(3):498-504. PubMed ID: 32647424
[TBL] [Abstract][Full Text] [Related]
29. [Effect of methotrexate on the immune response in selected experimental models].
Zimecki M; Artym J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():226-35. PubMed ID: 15114258
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.
Hu YH; Zhou L; Wang SS; Jing X; Guo HL; Sun F; Zhang Y; Chen F; Xu J; Ji X
Curr Pharm Des; 2019; 25(6):627-634. PubMed ID: 30931851
[TBL] [Abstract][Full Text] [Related]
31. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
Wollina U; Ständer K; Barta U
Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
[TBL] [Abstract][Full Text] [Related]
32. Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice with Methotrexate-Induced Hepatoxicity.
Wang C; Zhao S; Xu Y; Sun W; Feng Y; Liang D; Guan Y
Drug Des Devel Ther; 2022; 16():3877-3891. PubMed ID: 36388083
[TBL] [Abstract][Full Text] [Related]
33. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
Seither RL; Rape TJ; Goldman ID
Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
[TBL] [Abstract][Full Text] [Related]
34. Protective Mechanisms of Thymoquinone on Methotrexate-induced Intestinal Toxicity in Rats.
El-Sheikh AA; Morsy MA; Hamouda AH
Pharmacogn Mag; 2016 Jan; 12(Suppl 1):S76-81. PubMed ID: 27041864
[TBL] [Abstract][Full Text] [Related]
35. Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response.
Yan H; Su R; Xue H; Gao C; Li X; Wang C
Front Immunol; 2021; 12():789334. PubMed ID: 34975886
[TBL] [Abstract][Full Text] [Related]
36. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature].
Manganelli P; Troise Rioda W
Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309
[TBL] [Abstract][Full Text] [Related]
37. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.
Kotur N; Lazic J; Ristivojevic B; Stankovic B; Gasic V; Dokmanovic L; Krstovski N; Milosevic G; Janic D; Zukic B; Pavlovic S
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344632
[TBL] [Abstract][Full Text] [Related]
39. Brief Update on Dermatologic Uses of Methotrexate.
Shah RA; Nwannunu CE; Limmer AL; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Nov; 24(6):5-8. PubMed ID: 31801013
[TBL] [Abstract][Full Text] [Related]
40. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
